Compare $BIOQ vs $NNVC | Chartloom

Compare

$BIOQ vs $NNVC

Bioqual Inc · NanoViricides, Inc

BIOQ

Bioqual Inc

NNVC

NanoViricides, Inc

Compare $BIOQ vs $NNVC

Comparing Bioqual Inc and NanoViricides, Inc

BIOQBioqual Inc

NNVCNanoViricides, Inc

BIOQBioqual Inc

Market cap

$29M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-19.4%

YTD performance

-14.3%

52W performance

-40.0%

FCF yield

20.2%

NNVCNanoViricides, Inc

Market cap

$33M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

7.4%

52W performance

-9.1%

FCF yield

-23.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BIOQ

NNVC

Detailed metrics comparison

BIOQ

Bioqual Inc

NNVC

NanoViricides, Inc

Market Cap

BIOQ$29M

NNVC$33M

Enterprise Value

BIOQ$18M

NNVC$30M

Price

BIOQ$33.00

NNVC$1.30

P/E Ratio

BIOQN/A

NNVCN/A

P/S Ratio

BIOQ0.69x

NNVC0.00x

EV/Sales

BIOQ0.43x

NNVC0.00x

EV/EBITDA

BIOQ7.55x

NNVC0.00x

P/B Ratio

BIOQ0.84x

NNVC3.76x

P/FCF Ratio

BIOQ4.95x

NNVCN/A

EV/FCF

BIOQ3.05x

NNVC-3.88x

PEG Ratio

BIOQN/A

NNVCN/A

Forward P/E (NTM)

BIOQN/A

NNVCN/A

Forward P/S (NTM)

BIOQN/A

NNVCN/A

Revenue (TTM)

BIOQ$42M

NNVC$0

Revenue Growth (YoY)

BIOQ-19.4%

NNVCN/A

Forward Rev Growth

BIOQ0.0%

NNVC0.0%

Gross Margin (TTM)

BIOQ7.9%

NNVC0.0%

Operating Margin (TTM)

BIOQ0.0%

NNVC0.0%

EBITDA Margin (TTM)

BIOQ-0.1%

NNVC0.0%

Net Margin (TTM)

BIOQ-2.9%

NNVC0.0%

FCF Margin (TTM)

BIOQ14.0%

NNVCN/A

Net Income (TTM)

BIOQ$-1M

NNVC$-8M

FCF (TTM)

BIOQ$6M

NNVC$-8M

EPS (TTM)

BIOQ-$1.38

NNVC-$0.37

ROE (TTM)

BIOQ-346.0%

NNVC-9111.0%

ROA (TTM)

BIOQ-193.0%

NNVC-8074.0%

ROIC (TTM)

BIOQ-346.0%

NNVC-9111.0%

Cash

BIOQ$11M

NNVC$3M

Debt

BIOQ$0

NNVC$0

Net Cash/Debt

BIOQ$11M

NNVC$3M

Current Ratio (TTM)

BIOQ4.01x

NNVC2.66x

Quick Ratio (TTM)

BIOQ3.91x

NNVC2.35x

Debt/Equity (TTM)

BIOQ0.00x

NNVC0.00x

Debt/Assets (TTM)

BIOQ0.0%

NNVC0.0%

Interest Coverage (TTM)

BIOQN/A

NNVCN/A

Net Debt/EBITDA (TTM)

BIOQ0.00x

NNVC0.00x

Beta

BIOQ-0.48

NNVC1.91

52W Performance

BIOQ-40.0%

NNVC-9.1%

YTD Performance

BIOQ-14.3%

NNVC7.4%

% from 52W High

BIOQ-69.6%

NNVC-41.7%

% from 52W Low

BIOQ1.5%

NNVC52.9%

Asset Turnover (TTM)

BIOQ0.66x

NNVC0.00x

FCF Yield (TTM)

BIOQ20.2%

NNVC-23.6%

Earnings Yield (TTM)

BIOQ-4.2%

NNVC-24.9%

Dividend Yield (TTM)

BIOQN/A

NNVCN/A

Rule of 40

BIOQ-5.4

NNVC0.0

EV/GP/RG

BIOQN/A

NNVCN/A

Ticker research

View BIOQ research View NNVC research

Metric	BIOQ Bioqual Inc	NNVC NanoViricides, Inc
Market & Valuation
Market Cap	$29M	$33M
Enterprise Value	$18M	$30M
Price	$33.00	$1.30
P/E Ratio	N/A	N/A
P/S Ratio	0.69x	0.00x
EV/Sales	0.43x	0.00x
EV/EBITDA	7.55x	0.00x
P/B Ratio	0.84x	3.76x
P/FCF Ratio	4.95x	N/A
EV/FCF	3.05x	-3.88x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$42M	$0
Revenue Growth (YoY)	-19.4%	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	7.9%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-0.1%	0.0%
Net Margin (TTM)	-2.9%	0.0%
FCF Margin (TTM)	14.0%	N/A
Net Income (TTM)	$-1M	$-8M
FCF (TTM)	$6M	$-8M
EPS (TTM)	-$1.38	-$0.37
ROE (TTM)	-346.0%	-9111.0%
ROA (TTM)	-193.0%	-8074.0%
ROIC (TTM)	-346.0%	-9111.0%
Financial Health
Cash	$11M	$3M
Debt	$0	$0
Net Cash/Debt	$11M	$3M
Current Ratio (TTM)	4.01x	2.66x
Quick Ratio (TTM)	3.91x	2.35x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.48	1.91
52W Performance	-40.0%	-9.1%
YTD Performance	-14.3%	7.4%
% from 52W High	-69.6%	-41.7%
% from 52W Low	1.5%	52.9%
Efficiency & Yields
Asset Turnover (TTM)	0.66x	0.00x
FCF Yield (TTM)	20.2%	-23.6%
Earnings Yield (TTM)	-4.2%	-24.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-5.4	0.0
EV/GP/RG	N/A	N/A
Ticker research	View BIOQ research	View NNVC research

Valuation

P/S Ratio

NNVC

0.00x

BIOQ

0.69x

EV/FCF

NNVC

-3.88x

BIOQ

3.05x

Growth & revenue

Revenue Growth TTM

BIOQ

-19.4%

Forward Revenue Growth

BIOQ

0.0%

NNVC

0.0%

Profitability & performance

Gross Margin

BIOQ

7.9%

NNVC

0.0%

ROE

BIOQ

-346.0%

NNVC

-9111.0%

FCF Yield %

BIOQ

20.2%

NNVC

-23.6%

52-Week Performance

NNVC

-9.1%

BIOQ

-40.0%

Detailed metrics comparison

BIOQ

Bioqual Inc

NNVC

NanoViricides, Inc

Market Cap

BIOQ$29M

NNVC$33M

Enterprise Value

BIOQ$18M

NNVC$30M

Price

BIOQ$33.00

NNVC$1.30

P/E Ratio

BIOQN/A

NNVCN/A

P/S Ratio

BIOQ0.69x

NNVC0.00x

EV/Sales

BIOQ0.43x

NNVC0.00x

EV/EBITDA

BIOQ7.55x

NNVC0.00x

P/B Ratio

BIOQ0.84x

NNVC3.76x

P/FCF Ratio

BIOQ4.95x

NNVCN/A

EV/FCF

BIOQ3.05x

NNVC-3.88x

PEG Ratio

BIOQN/A

NNVCN/A

Forward P/E (NTM)

BIOQN/A

NNVCN/A

Forward P/S (NTM)

BIOQN/A

NNVCN/A

Revenue (TTM)

BIOQ$42M

NNVC$0

Revenue Growth (YoY)

BIOQ-19.4%

NNVCN/A

Forward Rev Growth

BIOQ0.0%

NNVC0.0%

Gross Margin (TTM)

BIOQ7.9%

NNVC0.0%

Operating Margin (TTM)

BIOQ0.0%

NNVC0.0%

EBITDA Margin (TTM)

BIOQ-0.1%

NNVC0.0%

Net Margin (TTM)

BIOQ-2.9%

NNVC0.0%

FCF Margin (TTM)

BIOQ14.0%

NNVCN/A

Net Income (TTM)

BIOQ$-1M

NNVC$-8M

FCF (TTM)

BIOQ$6M

NNVC$-8M

EPS (TTM)

BIOQ-$1.38

NNVC-$0.37

ROE (TTM)

BIOQ-346.0%

NNVC-9111.0%

ROA (TTM)

BIOQ-193.0%

NNVC-8074.0%

ROIC (TTM)

BIOQ-346.0%

NNVC-9111.0%

Cash

BIOQ$11M

NNVC$3M

Debt

BIOQ$0

NNVC$0

Net Cash/Debt

BIOQ$11M

NNVC$3M

Current Ratio (TTM)

BIOQ4.01x

NNVC2.66x

Quick Ratio (TTM)

BIOQ3.91x

NNVC2.35x

Debt/Equity (TTM)

BIOQ0.00x

NNVC0.00x

Debt/Assets (TTM)

BIOQ0.0%

NNVC0.0%

Interest Coverage (TTM)

BIOQN/A

NNVCN/A

Net Debt/EBITDA (TTM)

BIOQ0.00x

NNVC0.00x

Beta

BIOQ-0.48

NNVC1.91

52W Performance

BIOQ-40.0%

NNVC-9.1%

YTD Performance

BIOQ-14.3%

NNVC7.4%

% from 52W High

BIOQ-69.6%

NNVC-41.7%

% from 52W Low

BIOQ1.5%

NNVC52.9%

Asset Turnover (TTM)

BIOQ0.66x

NNVC0.00x

FCF Yield (TTM)

BIOQ20.2%

NNVC-23.6%

Earnings Yield (TTM)

BIOQ-4.2%

NNVC-24.9%

Dividend Yield (TTM)

BIOQN/A

NNVCN/A

Rule of 40

BIOQ-5.4

NNVC0.0

EV/GP/RG

BIOQN/A

NNVCN/A

Ticker research

View BIOQ research View NNVC research

Metric	BIOQ Bioqual Inc	NNVC NanoViricides, Inc
Market & Valuation
Market Cap	$29M	$33M
Enterprise Value	$18M	$30M
Price	$33.00	$1.30
P/E Ratio	N/A	N/A
P/S Ratio	0.69x	0.00x
EV/Sales	0.43x	0.00x
EV/EBITDA	7.55x	0.00x
P/B Ratio	0.84x	3.76x
P/FCF Ratio	4.95x	N/A
EV/FCF	3.05x	-3.88x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$42M	$0
Revenue Growth (YoY)	-19.4%	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	7.9%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-0.1%	0.0%
Net Margin (TTM)	-2.9%	0.0%
FCF Margin (TTM)	14.0%	N/A
Net Income (TTM)	$-1M	$-8M
FCF (TTM)	$6M	$-8M
EPS (TTM)	-$1.38	-$0.37
ROE (TTM)	-346.0%	-9111.0%
ROA (TTM)	-193.0%	-8074.0%
ROIC (TTM)	-346.0%	-9111.0%
Financial Health
Cash	$11M	$3M
Debt	$0	$0
Net Cash/Debt	$11M	$3M
Current Ratio (TTM)	4.01x	2.66x
Quick Ratio (TTM)	3.91x	2.35x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.48	1.91
52W Performance	-40.0%	-9.1%
YTD Performance	-14.3%	7.4%
% from 52W High	-69.6%	-41.7%
% from 52W Low	1.5%	52.9%
Efficiency & Yields
Asset Turnover (TTM)	0.66x	0.00x
FCF Yield (TTM)	20.2%	-23.6%
Earnings Yield (TTM)	-4.2%	-24.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-5.4	0.0
EV/GP/RG	N/A	N/A
Ticker research	View BIOQ research	View NNVC research